Assistant Professor, Medicine, Perelman School of Medicine
Cardiology
Dr. Bonnie Ky, MD
|
|
Give Review
Dr. Bonnie Ky works in the field of Cardiology. She researched medicine at Perelman School of Medicine at the University of Pennsylvania. She received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Dr. Bonnie Ky is a published MD. She published 45 publications, including: 'A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results.' Bonnie accepts Medicare payments and is listed with Medicare.gov.
Publications
- A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results.
- Roadmap for biomarkers of cancer therapy cardiotoxicity.
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.
- Sex Differences in the Incidence of Peripheral Artery Disease in the Chronic Renal Insufficiency Cohort.
- Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure.
- ST2 and Patient Prognosis in Chronic Heart Failure.
- Multimarker Testing With ST2 in Chronic Heart Failure.
- Patterns of cardiac toxicity associated with irreversible proteasome inhibition in the treatment of multiple myeloma.
- Cancer and cardiovascular Disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and tra...
- Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes.
- Biomarker predictors of cardiac hospitalization in Chronic heart failure: a recurrent event analysis.
- Strain improves risk prediction beyond ejection fraction in Chronic systolic heart failure.
- The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer.
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
- Ventricular-arterial coupling, remodeling, and prognosis in Chronic heart failure.
- Emerging paradigms in cardiomyopathies associated with cancer therapies.
- Longitudinal Strain in Friedreich Ataxia: A Potential Marker for Early Left Ventricular Dysfunction.
- Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.
- Development and evaluation of multi-marker risk scores for clinical prognosis.
- Left Ventricular Remodeling in Human Heart Failure: Quantitative Echocardiographic Assessment of 1,794 Patients.
- Defining the Role of ST2: A Multimarker Approach?
- Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.
- Physical performance and frailty in chronic kidney Disease.
- Heart failure associated with sunitinib: lessons learned from animal models.
- The vascular marker soluble fms-like tyrosine kinase 1 is associated with Disease severity and adverse outcomes in chronic heart failure.
- Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
- The Utility of Prescreening Transesophageal Echocardiograms: A Prospective Study.
- Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
- Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
- High-sensitivity ST2 for prediction of adverse outcomes in Chronic heart failure.
- Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels.
- Gender differences in cardiac remodeling and clinical outcomes in Chronic stable angina pectoris (from the ACTION Trial).
- Transthoracic and transesophageal echocardiography for the indication of suspected infective Endocarditis: vegetations, blood cultures and imaging.
- Common variants in HSPB7 and FRMD4B associated with advanced Heart failure.
- Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with Heart failure.
- Neuregulin-1 beta is associated with Disease severity and adverse outcomes in chronic heart failure.
- Hand-carried echocardiography for assessment of left ventricular filling and ejection fraction in the surgical intensive care unit.
- Application of appropriateness criteria in outpatient transthoracic echocardiography.
- The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
- Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence-assisted border detection.
- Differentiation syndrome in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- von Willebrand Disease and coronary artery Disease: a contemporary review.
- Type III hyperlipoproteinemia unmasked by HIV anti-retroviral therapy.
- The effects of statin therapy on plasma markers of inflammation in patients without vascular Disease.
Schools
Perelman School of Medicine University of Pennsylvania
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1497816193 | |
| NPPES Provider LastName | KY | |
| NPPES Provider FirstName | BONNIE | |
| NPPES Provider ZIPCode | 191044306 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 146.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497816193 |
| Last Name Of The Provider | KY |
| First Name Of The Provider | BONNIE |
| View All |
Similar Doctors
|
|
Dr. Amit C. Ladani, MD |
|
|
Dr. Christopher J. Damm, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mital P. Sheth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fahd A. Chaudhry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig M. Alpert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlo R. Bartoli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Hong, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jonathan M. Cox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary M. Gertz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arnold Gash, MD |
|
|
Dr. Nehal Mehta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph J. Verdino, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charles T. Leng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell J. Marder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig A. Frankil, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Hirshfeld Jr., MD
This Doctor is OpenDoctor Recommended.
|